Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC — Stella

Home/Peritoneal Carcinomatosis/Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

View on ClinicalTrials.gov

Recruiting

Back to Peritoneal Carcinomatosis trials

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

University of Kentucky, Lexington, Kentucky

University of Vermont Medical Center, Burlington, Vermont

Key details

Phase

Safety & dosing

Sponsor

Prakash Pandalai

Enrollment target

~100 participants

Started

June 2021

Primary completion

February 2028

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.